Fig. 2. DNA sequencing of PCR products with abnormal ddF patterns. The arrows indicate the locations of nucleotides that differ from the published sequence for wild-type human factor XI.28 (A) exon 5: C to T at nucleotide 472, no amino acid change; (B) exon 5: G to T at nucleotide 446, changing glutamic acid 117 to a stop codon; (C) exon 7: A to G at nucleotide 774, changing glutamine 226 to arginine; (D) exon 8: G to A (top arrow) at nucleotide 840, changing serine 248 to glutamine and A to G (bottom arrow) at nucleotide 844, no amino acid change; (E) exon 9: T to C at nucelotide 944, changing phenylalanine 283 to leucine; and (F) exon 11: T to C at nucleotide 1234, no amino acid change.
Fig. 2.

DNA sequencing of PCR products with abnormal ddF patterns. The arrows indicate the locations of nucleotides that differ from the published sequence for wild-type human factor XI.28 (A) exon 5: C to T at nucleotide 472, no amino acid change; (B) exon 5: G to T at nucleotide 446, changing glutamic acid 117 to a stop codon; (C) exon 7: A to G at nucleotide 774, changing glutamine 226 to arginine; (D) exon 8: G to A (top arrow) at nucleotide 840, changing serine 248 to glutamine and A to G (bottom arrow) at nucleotide 844, no amino acid change; (E) exon 9: T to C at nucelotide 944, changing phenylalanine 283 to leucine; and (F) exon 11: T to C at nucleotide 1234, no amino acid change.

or Create an Account

Close Modal
Close Modal